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Combating antimicrobial 
resistance: quality 
standards for prescribing 
for respiratory infections 
in Vietnam
Antimicrobial resistance is recognised as 
a serious global health threat requiring 
global action. However, much work 
remains to translate global strategies 
to combat antimicrobial resistance 
into national policy and action. In low-
income and middle-income countries 
where vulnerable health-care systems 
require investment within constrained 
budgets, antimicrobial resistance 
strategies might not be prioritised, and 
indeed equitable versus restricted access 
to antibiotics present a conflicting 
challenge.1
Engaging the right stakeholders 
nationally and contextualising scientiﬁ c 
evidence to address concrete policy 
issues moves antimicrobial stewardship 
strategies into action.2 High-burden 
diseases present an important starting 
point. In Vietnam, severe acute 
respiratory tract infections and chronic 
obstructive pulmonary disease (COPD) 
together account for 8% of mortality.3 
However, antibiotic prescribing is often 
inappropriate in preclinical and clinical 
disease stages, and is commonly 
done against local and international 
evidence-based guidelines.4,5
The Ministry of Health (MOH), 
Vietnam, issued a national action plan 
on antimicrobial resistance in June, 
2013, supported by WHO.6 Building on 
their situation analysis of antimicrobial 
resistance and surveillance,7 and 
previous MOH success to establish 
national quality standards for acute 
stroke,8 Oxford University Clinical 
Research Unit and the Vietnam MOH 
convened a working group to develop 
evidence-informed quality standards 
for appropriate inpatient antibiotic 
prescribing for community-acquired 
pneumonia and acute exacerbation 
of COPD. Quality standards translate 
best practice recommendations 
from international guidelines into 
high-priority, implementable, and 
measurable clinical activities relevant 
for the local context, through local 
stakeholder collaboration.
In June, 2016, we presented the 
draft of the quality standards for 
community-acquired pneumonia 
and acute exacerbation of COPD to a 
national committee convened by MOH, 
comprising MOH officials, and over 
40 managers, physicians, pharmacists, 
and microbiologists from central and 
provincial hospitals across Vietnam. 
Although there was rapid consensus 
to adopt international principles of 
matching route of administration to 
duration of administration, matching 
breadth of spectrum to disease severity, 
and justifying any deviation, there was 
equal recognition that international 
standards need local adaptation. 
Thus, the committee agreed on the 
need for thorough clinical diagnostic 
assessment, including medical and 
antibiotic histories, using locally 
available microbiological tests to 
inform antibiotic prescription. 
However, in an environment with high 
prevalence of antimicrobial resistance, 
patients self-medicating with 
over-the-counter antibiotics before 
presenting to hospital, and absence 
of national surveillance, determining 
appropriate first-line therapy was 
more challenging than establishing 
the standards for thorough clinical 
diagnostic assessment.5,7 Further 
collection and analysis of susceptibility 
data from the Vietnam resistance 
network of 16 hospitals2 will allow 
formal standards to be recommended.
Establishing national quality 
standards coproduced with local 
clinicians is a massive step towards 
combating antimicrobial resistance in 
Vietnam. Additionally, local evidence, 
engagement, and contextualisation are 
critical for transforming global discourse 
into global action on antimicrobial 
resistance. Implementation will be 
challenging, but with national opinion 
leaders championing the cause, we have 
great optimism for success.
